{
    "nctId": "NCT05073120",
    "briefTitle": "Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib",
    "officialTitle": "Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "assess HCPs' knowledge and understanding of the key information included in the Piqray Prescriber's/HCP Guide for hyperglycemia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Has prescribed Piqray to at least 1 locally advanced or MBC patient within 6 months prior to completing the survey.\n* Provides permission to share their anonymized responses in aggregate with EMA or NCAs, if requested.\n\nExclusion Criteria:\n\nHCPs who are direct employees of Novartis, the EMA (or any other regulatory bodies), or ICON.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}